Pharmacists in Palos Verdes Estates, CA Accepting Medicare

6 Pharmacists found. Showing 1 - 6

Gavin Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30019 Hawthorne Blvd, Palos Verdes Estates, CA 90275 Phone: 310-377-6829

Jennifer Kawamura Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30019 Hawthorne Blvd, Palos Verdes Estates, CA 90275 Phone: 310-377-6829

Mrs. Shelly Mcfadden Kumar, PHARM.D. Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 2501 Via Rivera, Palos Verdes Estates, CA 90274 Phone: 310-544-0337

Attah Nazerzadeh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2 Pheasant Ln, Palos Verdes Estates, CA 90274 Phone: 310-308-0944

Vahid Bordbar Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 2325 Palos Verdes Dr W Ste 220, Palos Verdes Estates, CA 90274 Phone: 424-327-2990    Fax: 424-327-2996

Mrs. Brittney Wong Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30019 Hawthorne Blvd, Palos Verdes Estates, CA 90275 Phone: 310-377-6829

News Archive

Left side grafting has lower risk to donors; small graft size not the only cause of 'small-for-size graft syndrome'

A recent study by doctors at Shinshu University, School of Medicine, in Japan determined that left side grafting has lower risk to donors compared to grafts taken from the right lobe, and it appears to be the procedure of choice for adult-to-adult living donor liver transplantation (LDLT).

Recreational drugs more likely to be tried for the first time in summer, study shows

American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Miracor receives three new U.S. patents for novel PICSO system to treat STEMI

Miracor Medical Systems announced today that it has been granted three new U.S. patents covering a unique dual balloon method and the new "Wien Algorithm" of its novel PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) system that ensures a stable and repeatable PICSO treatment designed to improve myocardial perfusion following primary PCI (Percutaneous Coronary Intervention, or angioplasty).

Plan B - Lancet has a go at the FDA

A well known international medical journal has called on the acting FDA Commissioner Andrew von Eschenbach to adopt an independent stance and follow the best judgment of it's expert staff and scientific advisers, even when that means incurring the wrath of patients' groups, industry, Congress, and even the White House.

Read more Medical News

› Verified 7 days ago